Logo image of CVRX

CVRX INC (CVRX) Stock Fundamental Analysis

NASDAQ:CVRX - US1266381052 - Common Stock

7.73 USD
-0.12 (-1.53%)
Last: 9/2/2025, 1:06:10 PM
Fundamental Rating

2

Taking everything into account, CVRX scores 2 out of 10 in our fundamental rating. CVRX was compared to 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CVRX have multiple concerns. CVRX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CVRX had negative earnings in the past year.
In the past year CVRX has reported a negative cash flow from operations.
CVRX had negative earnings in each of the past 5 years.
In the past 5 years CVRX always reported negative operating cash flow.
CVRX Yearly Net Income VS EBIT VS OCF VS FCFCVRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

CVRX has a worse Return On Assets (-43.70%) than 63.68% of its industry peers.
Looking at the Return On Equity, with a value of -90.19%, CVRX is doing worse than 62.63% of the companies in the same industry.
Industry RankSector Rank
ROA -43.7%
ROE -90.19%
ROIC N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
CVRX Yearly ROA, ROE, ROICCVRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

CVRX has a better Gross Margin (83.54%) than 93.68% of its industry peers.
In the last couple of years the Gross Margin of CVRX has grown nicely.
CVRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
CVRX Yearly Profit, Operating, Gross MarginsCVRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

CVRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CVRX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CVRX has more shares outstanding
The debt/assets ratio for CVRX is higher compared to a year ago.
CVRX Yearly Shares OutstandingCVRX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CVRX Yearly Total Debt VS Total AssetsCVRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -4.51, we must say that CVRX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -4.51, CVRX is not doing good in the industry: 67.37% of the companies in the same industry are doing better.
CVRX has a Debt/Equity ratio of 0.85. This is a neutral value indicating CVRX is somewhat dependend on debt financing.
CVRX has a worse Debt to Equity ratio (0.85) than 74.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z -4.51
ROIC/WACCN/A
WACC8.61%
CVRX Yearly LT Debt VS Equity VS FCFCVRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 11.99 indicates that CVRX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 11.99, CVRX belongs to the top of the industry, outperforming 95.79% of the companies in the same industry.
CVRX has a Quick Ratio of 10.78. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 10.78, CVRX belongs to the best of the industry, outperforming 95.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.99
Quick Ratio 10.78
CVRX Yearly Current Assets VS Current LiabilitesCVRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.97% over the past year.
CVRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.11%.
CVRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.30% yearly.
EPS 1Y (TTM)17.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.31%
Revenue 1Y (TTM)23.11%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%15.09%

3.2 Future

The Earnings Per Share is expected to grow by 8.33% on average over the next years. This is quite good.
CVRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.43% yearly.
EPS Next Y23.03%
EPS Next 2Y13.36%
EPS Next 3Y10.67%
EPS Next 5Y8.33%
Revenue Next Year9.98%
Revenue Next 2Y14.2%
Revenue Next 3Y17.48%
Revenue Next 5Y19.43%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CVRX Yearly Revenue VS EstimatesCVRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
CVRX Yearly EPS VS EstimatesCVRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CVRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CVRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVRX Price Earnings VS Forward Price EarningsCVRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVRX Per share dataCVRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.36%
EPS Next 3Y10.67%

More info and screens

0

5. Dividend

5.1 Amount

CVRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CVRX INC

NASDAQ:CVRX (9/2/2025, 1:06:10 PM)

7.73

-0.12 (-1.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners69.78%
Inst Owner Change-9.72%
Ins Owners4.28%
Ins Owner Change0.87%
Market Cap202.14M
Analysts80
Price Target11.83 (53.04%)
Short Float %8.15%
Short Ratio7.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.68%
Min EPS beat(2)-7.47%
Max EPS beat(2)8.82%
EPS beat(4)1
Avg EPS beat(4)-7.51%
Min EPS beat(4)-19.26%
Max EPS beat(4)8.82%
EPS beat(8)3
Avg EPS beat(8)-10.91%
EPS beat(12)7
Avg EPS beat(12)-4.26%
EPS beat(16)10
Avg EPS beat(16)-2.61%
Revenue beat(2)1
Avg Revenue beat(2)-4.37%
Min Revenue beat(2)-9.51%
Max Revenue beat(2)0.76%
Revenue beat(4)1
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)0.76%
Revenue beat(8)2
Avg Revenue beat(8)-1.8%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)9
Avg Revenue beat(16)0.96%
PT rev (1m)-1.69%
PT rev (3m)-32.56%
EPS NQ rev (1m)-2.63%
EPS NQ rev (3m)-2.48%
EPS NY rev (1m)-1.14%
EPS NY rev (3m)-1.65%
Revenue NQ rev (1m)-2.64%
Revenue NQ rev (3m)-13.62%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-2.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.7
P/FCF N/A
P/OCF N/A
P/B 3.49
P/tB 3.49
EV/EBITDA N/A
EPS(TTM)-2.1
EYN/A
EPS(NY)-1.92
Fwd EYN/A
FCF(TTM)-1.51
FCFYN/A
OCF(TTM)-1.5
OCFYN/A
SpS2.09
BVpS2.22
TBVpS2.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.7%
ROE -90.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.54%
FCFM N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.27%
Cap/Sales 0.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.99
Quick Ratio 10.78
Altman-Z -4.51
F-Score3
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)167.13%
Cap/Depr(5y)316.6%
Cap/Sales(3y)2.41%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.31%
EPS Next Y23.03%
EPS Next 2Y13.36%
EPS Next 3Y10.67%
EPS Next 5Y8.33%
Revenue 1Y (TTM)23.11%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%15.09%
Revenue Next Year9.98%
Revenue Next 2Y14.2%
Revenue Next 3Y17.48%
Revenue Next 5Y19.43%
EBIT growth 1Y7.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.23%
EBIT Next 3Y9.14%
EBIT Next 5YN/A
FCF growth 1Y13.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.06%
OCF growth 3YN/A
OCF growth 5YN/A